| |
| The Expert's View 1: Clinical |
| GENEROUSLY SUPPORTED BY SERONO LTD |
|
|
|
| 07.30-08.15 |
Queen's Suite 1 Chair: Conway G
(London) |
|
|
Precocious puberty
Stanhope R (London) |
|
|
|
|
|
|
| The Expert's View 2: Clinical |
| 07.30-08.15 |
Queen's Suite 2 Chair: Vanderpump M
(London) |
|
|
Amiodarone, lithium and thyroid
dysfunction
Sheppard M (Birmingham) |
|
|
|
|
|
|
| The Expert's View 3: Science |
| 07.30-08.15 |
King's Suite Chair: Bland R (Warwick) |
|
|
The polypeptide hormone stanniocalcin, no
longer just a fish-tale
Wagner G (London, Canada) |
|
|
|
|
|
|
| Clinical Endocrinology Trust Lecture |
| 08.30-09.15 |
Main Auditorium Chair: Wass JAH
(Oxford) |
| S3 |
08.30 |
Thyroid disease - causes and effects
Franklyn JA (Birmingham) |
|
|
|
|
|
|
| COFFEE |
|
| 09.15-09.45 |
Hall D |
| |
|
|
|
|
| Symposium 4: Intracellular transport of
steroids |
| 09.45-11.45 |
Queen's Suite 1 Chair: Hewison M
(Birmingham) |
| S16 |
09.45 |
An introduction to lipid rafts and their
role in protein targeting
Shennan K (Aberdeen) |
|
|
|
| S17 |
10.15 |
The steroid hormone response element
binding proteins
Adams JS (Los Angeles, USA) |
|
|
|
| S18 |
10.45 |
The molecular mechanism of nuclear
trafficking
Stewart M (Cambridge) |
|
|
|
| S19 |
11.15 |
Intracellular trafficking of vitamin D
receptors and interacting proteins
Barsony J (Bethesda, USA) |
|
|
|
|
|
|
| Clinical Management Workshop 2: HRT in women -
who should get what? |
| 09.45-11.45 |
Main Auditorium Chair: Buckler H
(Manchester) |
| S41 |
09.45 |
Current state of HRT in post-menopausal
women
Prelevic G (London) |
|
|
|
| S42 |
10.15 |
Hormone replacement in pre-menopausal
women
Conway GS (London) |
|
|
|
| S43 |
10.45 |
DHEA and its role in women
Allolio B (Würzburg, Germany) |
|
|
|
| Oral Communications 3: Neuroendocrinology |
| 09.45-11.45 |
Queen's Suite 2 Chairs: Buckingham
JC (London) & Davis JRE (Manchester) |
| OC18 |
09.45 |
Genetic ablation of the AgRP neuron leads
to a lean, hypophagic phenotype
Bewick GA, Gardiner JV, Dhillo WS, Kent AS, Ghatei MA & Bloom SR |
|
|
NOVARTIS AWARD WINNER (NP1) ALSO PRESENTED AS A POSTER |
|
|
|
| OC19 |
10.00 |
The nadir growth hormone after an
octreotide test dose predicts the long term efficacy of somatostatin analogue
therapy in acromegaly
Gilbert JA, McGregor AM & Aylwin SJB |
|
|
|
| OC20 |
10.15 |
Transcriptional activation of the
prolactin gene by TNF-alpha is mediated via NFkB
Friedrichsen S, Wilding M, Harper C, Nelson G, Spiller DS, White MRH & Davis
JRE |
|
|
|
| OC21 |
10.30 |
Adenosine expression and function in the
anterior pituitary gland
Francis K, Pexa A, Lewis BM, McNicol AM, Jasani B, Deussen A, Scanlon
MF, Rees DA & Ham J |
|
|
|
| OC22 |
10.45 |
Modulators of the SUR2B/Kir6.1
ATP-sensitive K+ channel regulate annexin 1 release in the TtT/GF
folliculostellate cell line
Payne JP, Morris JF, Solito E & Buckingham JC |
|
|
|
| OC23 |
11.00 |
Ghrelin and cannabinoid interactions on
food intake
Korbonits M, Tucci SA, Rogers EK & Kirkham TC |
|
|
|
| OC24 |
11.15 |
Feeding effects of the gut hormones ghrelin, peptide YY (3-36) and
oxyntomodulin in lean and obese mice
Druce MR, Neary NM, Small CJ, Monteiro M, Thompson EL, Ghatei MA & Bloom
SR |
|
|
|
| OC25 |
11.30 |
Does GH replacement increase the risk of
recurrence in patients with craniopharyngioma?
Karavitaki N, Warner JT, Shine B, Stratton IM, Turner HE & Wass JAH |
|
|
|
|
|
|
| Society for Endocrinology Extraordinary General
Meeting |
| 11.45-12.00 |
Main Auditorium |
| |
|
|
|
|
| LUNCH |
|
| 11.45-13.00 |
Hall D |
| |
|
|
|
|
| Attended Posters (even numbers) |
| 11.45-13.00 |
Hall D |
| |
|
|
|
|
| Novartis Awards Poster Session |
| 12.30-13.00 |
Hall D |
| |
|
|
|
|
| Molecular Endocrinology Workshop |
| 13.00-14.00 |
Queen's Suite 1 Chair: Davis JRE
(Manchester) |
| S57 |
13.00 |
Protein chip technology
Banks R (Leeds) |
|
|
|
|
|
|
| Schering Health Care Ltd Satellite Session |
| 13.00-14.00 |
Main Auditorium |
|
|
New quarterly intramuscular testosterone
undecanoate and the future of testosterone replacement therapy |
|
|
|
|
|
|
| Debate: Growth hormone in adults: did NICE get
it right? |
| 13.00-14.00 |
Queen's Suite 2 Chair: Shalet SM
(Manchester) |
| |
For: Barkan A (Ann Arbor, USA) Against: Wass JAH (Oxford) |
| |
|
| Symposium 5: Cardiovascular endocrinology |
| 14.00-16.00 |
Main Auditorium Chair: Bouloux P (London) |
| S20 |
14.00 |
Adipokines, metabolic syndrome and atherogenesis
Sattar N (Glasgow) |
|
|
|
| S21 |
14.30 |
Inflammatory markers in coronary heart disease
Danesh J (Cambridge) |
|
|
|
| S22 |
15.00 |
Endothelial function and atherogenesis
Deanfield JE (London) |
|
|
|
| S23 |
15.30 |
Oxidative stress and cardiovascular disease
Dominiczak AF (Glasgow) |
|
|
|
|
|
|
| Symposium 6: Novel approaches for defining
oestrogen action |
| 14.00-16.00 |
Queen's Suite 1 Chair: Parker M (London) |
| S24 |
14.00 |
Imaging of E2 action in vivo
Maggi A (Milan, Italy) |
|
|
|
| S25 |
14.30 |
New roles for oestrogens as revealed by models of oestrogen insufficiency
Simpson ER (Melbourne, Australia) |
|
|
|
| S26 |
15.00 |
Profiling in endometrium - genomic approaches to defining oestrogen action
Moggs JG (Macclesfield) |
|
|
|
| S27 |
15.30 |
Oestrogen receptors and growth factor interactions: implications for
cancer development and treatment
Nicholson RI, Hutcheson IR, Giles MG & Gee JMW (Cardiff) |
|
|
|
|
|
|
| Oral Communications 4: Steroids |
| 14.00-16.00 |
Queen's Suite 2 Chairs: Ray D (Manchester) & Adams
JS (Los Angeles, USA) |
| OC26 |
14.00 |
Identification of a defective gene in familial glucocorticoid deficiency
type 2 as an ACTH receptor accessory factor responsible for cell surface
trafficking
Metherell LA, Chapple JP, Cooray S, Naville D, Begeot M, Huebner
A, Cheetham ME & Clark AJL |
|
|
|
| OC27 |
14.15 |
Interaction of the ACTH receptor C-terminal tail with a nuclear envelope
protein
Doufexis M & Clark AJ |
|
|
|
| OC28 |
14.30 |
Impact of dietary chenodeoxycholic acid on the hypothalamic-pituitary-adrenal
axis in rats
McNeilly AS, Walker BR & Andrew R |
|
|
|
| OC29 |
14.45 |
Characterisation of a novel protein interacting with the glucocorticoid
receptor
Rice LM, Waters CE, Garside HJ, White A & Ray DW |
|
|
NOVARTIS AWARD WINNER (NP2) ALSO PRESENTED AS A POSTER |
|
|
|
| OC30 |
15.00 |
Cortisol, DHEA and DHEAS in severe sepsis - a paradigm revisited
Arlt W, Hammer F, Sanning P, Filko D, Allolio B, Stewart PM & Annane
D |
|
|
|
| OC31 |
15.15 |
Functional effects of mutations in the 11beta-hydroxylase (CYP11B1) gene
Barr M, Wilkinson DM, Holloway CD, Miller S, MacKenzie SM, Kazi
S, Fraser R, Connell JMC & Davies E |
|
|
|
| OC32 |
15.30 |
Differential induction of fibroblast 11beta-HSD1: a mechanism for tissue-specific
regulation of inflammation
Hardy RS, Cooper MS, Filer A, Parsonage G, Buckley CD, Stewart
PM & Hewison M |
|
|
|
| OC33 |
15.45 |
Generation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase
isozymes in the perfused mouse hindlimb
Dover AR, Hadoke PWF, Miller E, Newby DE & Walker BR |
|
|
|
| Nurses Session: Skeletal health |
| 14.00-16.00 |
King's Suite Chairs: Smethurst L (Manchester) & Campbell
K (Glasgow) |
| S50 |
14.00 |
Techniques of bone mass measurement
Alsop C (Manchester) |
|
|
|
| S51 |
14.30 |
Steroids and the skeleton
Francis RM (Newcastle) |
|
|
|
| S52 |
15.00 |
Management of osteoporosis
Selby PL (Manchester) |
|
|
|
| S53 |
15.30 |
Osteoporosis and fracture: the role of the endocrine nurse
Nelson DA (Glasgow) |
|
|
|
|
|
|
| TEA |
|
|
| 16.00-16.15 |
Hall D |
| |
|
|
|
|
| NURSES' TEA |
| GENEROUSLY SUPPORTED BY SERONO LTD |
|
|
|
| 16.00-16.30 |
Conference Suite |
| |
|
|
|
|
| The Expert's View 4: Science |
| 16.15-17.00 |
King's Suite Chair: Lowry P (Reading) |
|
|
The use of genomics to identify key transcriptional pathways of mammalian
implantation
Smith S (Glasgow) |
|
|
|
|
|
|
| The Expert's View 5: Clinical |
| 16.15-17.00 |
Queen's Suite 1 Chair: Arlt W (Birmingham) |
|
|
Controversies in androgen replacement
Bouloux P (London) |
|
|
|
|
|
|
| The Expert's View 6: Clinical |
| 16.15-17.00 |
Queen's Suite 2 Chair: Williams G (Bristol) |
|
|
Dyslipidaemias in diabetes
Durrington P (Manchester) |
|
|
|
|
|
|
| Society for Endocrinology Transatlantic
Medal Lecture |
| 17.00-17.45 |
Main Auditorium Chair: Bloom SR (London) |
| S4 |
17.00 |
Consequences from loss of estrogen receptor activity in endocrine physiology
Korach KS (Research Triangle Park, North Carolina, USA) |
|
|
|
|
|
|
| Ipsen Ltd Satellite Session |
| 18.00-19.00 |
Main Auditorium |
|
|
Would you recognise LOH if it walked into your clinic? Interactive case
presentations on the diagnosis and management of late-onset hypogonadism
(LOH) |
|
|
|
|
|
|
| BES Banquet |
|
| 19.30-late |
Majestic Hotel (ticket only) |